{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:58:24Z","timestamp":1783490304009,"version":"3.55.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":2006,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"China National Key Research and Development Plan","doi-asserted-by":"publisher","award":["2017YFC1700403"],"award-info":[{"award-number":["2017YFC1700403"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"China National Key Research and Development Plan","doi-asserted-by":"publisher","award":["2017YFC1700400"],"award-info":[{"award-number":["2017YFC1700400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1700403"],"award-info":[{"award-number":["2017YFC1700403"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1700400"],"award-info":[{"award-number":["2017YFC1700400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We aim to assess the effect of a lyophilized herbal injection on 90 day mortality and readmission rates in patients with acute heart failure (AHF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The AUGUST-AHF study is a multicentre, randomized, double-blind, placebo-controlled trial enrolling 1270 hospitalized patients for AHF. Patients are randomized to receive YiqiFumai lyophilized injection (5.2 g\/day) or placebo for 10 days, in addition to standard therapy, using a 1:1 ratio via an interactive web response system. The primary endpoint is the 90 day all-cause mortality or AHF readmission rates. Secondary endpoints include 180 day all-cause mortality or heart failure readmission rates, length of hospital stay for the indexed AHF, 90 day cardiac-specific mortality rate, occurrence of worsening heart failure through Day 10, changes in the Minnesota Living with Heart Failure Quality of Life scale score through Day 180, and 90 day major adverse cardiac events. Additional secondary endpoints include change in dyspnoea via visual analogue scale (VAS) and Likert 7-point comparator scale, N terminal pro-B-type natriuretic peptide value and New York Heart Association functional class, and the total amount of diuretics for the indexed AHF hospitalization. Study recruitment is expected to be completed by March 2021, and follow-up will end in September 2021. In an optional sub-study, patients will be followed up for 3 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To our best knowledge, AUGUST-AHF is the first study assessing the efficacy of a Chinese herbal injection in patients with AHF. The results will be valuable to guide clinicians in using YiqiFumai lyophilized injection, which was included in the latest Chinese Health Insurance Catalog.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12787","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T04:26:02Z","timestamp":1592799962000},"page":"3124-3133","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rationale and Design of the AUGUST-AHF Study"],"prefix":"10.1093","volume":"7","author":[{"given":"Jingjing","family":"Zhang","sequence":"first","affiliation":[{"name":"Beijing University of Chinese Medicine , Beijing ,","place":["China"]},{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehua","family":"Zhou","sequence":"additional","affiliation":[{"name":"Catholic Health System Internal Medicine Training Program, University at Buffalo , Buffalo, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine , Beijing ,","place":["China"]},{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine , Beijing ,","place":["China"]},{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine , Beijing ,","place":["China"]},{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Zhong","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine , Beijing ,","place":["China"]},{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu*","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcai","family":"Shang*","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"2026012114055417200_ehf212787-bib-0001","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"2016","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114055417200_ehf212787-bib-0002","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012114055417200_ehf212787-bib-0003","first-page":"760","article-title":"Chinese guidelines for the diagnosis and treatment of heart failure 2018","volume":"46","author":"Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association","year":"2018","journal-title":"Chinese Journal of Cardiology"},{"key":"2026012114055417200_ehf212787-bib-0004","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jacc.2008.10.041","article-title":"Acute heart failure syndromes","volume":"53","author":"Gheorghiade","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026012114055417200_ehf212787-bib-0005","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114055417200_ehf212787-bib-0006","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ejhf.890","article-title":"Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114055417200_ehf212787-bib-0007","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ehjcvp\/pvv046","article-title":"Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection","volume":"2","author":"Diez","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026012114055417200_ehf212787-bib-0008","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jjcc.2016.02.004","article-title":"A new approach to treatment of acute heart failure","volume":"67","author":"Goldsmith","year":"2016","journal-title":"J Cardiol"},{"key":"2026012114055417200_ehf212787-bib-0009","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1254\/jphs.12261FP","article-title":"Protective effects and active ingredients of Yi-Qi-Fu-Mai sterile powder against myocardial oxidative damage in mice","volume":"122","author":"Wang","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"2026012114055417200_ehf212787-bib-0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphs.2015.02.003","article-title":"Identification of schisandrin as a vascular endothelium protective component in YiqiFumai Powder Injection using HUVECs binding and HPLC-DAD-Q-TOF-MS\/MS analysis","volume":"129","author":"Li","year":"2015","journal-title":"JPharmacol Sci"},{"key":"2026012114055417200_ehf212787-bib-0011","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jep.2013.04.019","article-title":"Cardioprotective effects of the YiQiFuMai injection and isolated compounds on attenuating chronic heart failure via NF-\u03baB inactivation and cytokine suppression","volume":"148","author":"Xing","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"2026012114055417200_ehf212787-bib-0012","first-page":"2233","article-title":"Effects of YiqiFumai injection on cardiac function and heart failure markers in rats with chronic heart failure","volume":"42","author":"Zhang","year":"2015","journal-title":"Liaoning Journal of Traditional Chinese Medicine"},{"key":"2026012114055417200_ehf212787-bib-0013","first-page":"825","article-title":"Regulative effects of Yiqifumai injection on the activity of matrix metalloproteinase in rats with chronic heart failure","volume":"14","author":"Zhang","year":"2016","journal-title":"Chinese Journal of Integrative Medicine on Cardio-\/Cerebrovascular Disease"},{"key":"2026012114055417200_ehf212787-bib-0014","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jep.2017.02.032","article-title":"YiqiFumai powder injection attenuates coronary artery ligation-induced myocardial remodeling and heart failure through modulating MAPKs signaling pathway","volume":"202","author":"Pang","year":"2017","journal-title":"J Ethnopharmacol"},{"key":"2026012114055417200_ehf212787-bib-0015","volume-title":"National Healthcare Security Administration and the Ministry of Human Resources and Social Security issued a list of drugs for access to national health insurance negotiations in 2019","author":"National healthcare security administration","year":"2019"},{"key":"2026012114055417200_ehf212787-bib-0016","first-page":"1499","article-title":"Meta analysis on curative effects of YiqiFumai injection (lyophilization) for heart failure","volume":"17","author":"Xie","year":"2019","journal-title":"Chinese Journal of Integrative Medicine on Cardio-\/Cerebrovascular Disease"},{"key":"2026012114055417200_ehf212787-bib-0017","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/bmj.332.7556.1506","article-title":"Is restricted randomisation necessary?","volume":"332","author":"Hewitt","year":"2006","journal-title":"BMJ"},{"key":"2026012114055417200_ehf212787-bib-0018","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cardfail.2017.09.014","article-title":"Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China Heart Failure (China-HF) Registry","volume":"23","author":"Zhang","year":"2017","journal-title":"J Card Fail"},{"key":"2026012114055417200_ehf212787-bib-0019","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ejhf.1630","article-title":"Assessing the evidence-practice gap for heart failure in China: the Heart Failure Registry of Patient Outcomes (HERO) study design and baseline characteristics","volume":"22","author":"Li","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114055417200_ehf212787-bib-0020","first-page":"268","article-title":"Analysis and practice of reliability and validity evaluation of medication compliance in patients with chronic cardiovascular disease by Chinese version of MMAS-8","volume":"30","author":"Chen","year":"2019","journal-title":"China Pharmacy"},{"key":"2026012114055417200_ehf212787-bib-0021","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"2026012114055417200_ehf212787-bib-0022","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.2013.1954","article-title":"Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial","volume":"309","author":"Gheorghiade","year":"2013","journal-title":"JAMA"},{"key":"2026012114055417200_ehf212787-bib-0023","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"RELAXin in Acute Heart Failure (RELAX-AHF) Investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"2026012114055417200_ehf212787-bib-0024","first-page":"354","article-title":"Pharmacological effects and clinical research progress of YiqiFumai lyophilized injection","volume":"41","author":"Ju","year":"2018","journal-title":"Drug Evaluation Research"},{"key":"2026012114055417200_ehf212787-bib-0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrcardio.2015.14","article-title":"The vulnerable phase after hospitalization for heart failure","volume":"12","author":"Greene","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026012114055417200_ehf212787-bib-0026","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ejhf.598","article-title":"Targeting the vulnerable phase of heart failure: initiate novel therapies in stable patients prior to hospitalization","volume":"18","author":"Vaduganathan","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114055417200_ehf212787-bib-0027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012114055417200_ehf212787-bib-0028","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/eurheartj\/ehp458","article-title":"The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study","volume":"31","author":"Mebazaa","year":"2010","journal-title":"Eur Heart J"},{"key":"2026012114055417200_ehf212787-bib-0029","first-page":"448","article-title":"National Drug Standards (amendment) promulgated pieces","volume":"14","author":"Food S","year":"2013","journal-title":"Drug Stand China"},{"key":"2026012114055417200_ehf212787-bib-0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejheart.2004.04.007","article-title":"Non-compliance in patients with heart failure; how can we manage it?","volume":"7","author":"Van der Wal","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"2026012114055417200_ehf212787-bib-0031","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/eurjhf\/hft095","article-title":"Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document","volume":"15","author":"Zannad","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026012114055417200_ehf212787-bib-0032","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ejhf.516","article-title":"Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency","volume":"18","author":"Anker","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114055417200_ehf212787-bib-0033","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10557-018-6791-0","article-title":"Assessment of Complementary Treatment with YiqiFumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and design of a multicenter, randomized, controlled trial","volume":"32","author":"Wang","year":"2018","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12787","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12787","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12787","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/3124\/65807503\/eschf_7_5_3124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/5\/3124\/65807503\/eschf_7_5_3124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:06:23Z","timestamp":1769022383000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/5\/3124\/8372076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,6,22]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12787","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"2020-02-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}